I think that with all the new additions, MSprecise, new advisors, etc. it's only a matter of time before we get news that will shoot the sp up. What was a mistake, IMO, was that Gerald put out a timeline that was a overly optimistic. Some expectations were generated thinking Lympro would be ready to generate revenue, when reality was it wasn't quite there yet. Also, Q4-2014 uplist was a nice goal to try to achieve however he obviously didn't want to do a massive R/S, thus making an uplist at that time out of the question. I love where the company is headed, couldn't be more excited to be a share holder in fact. I only wish I had more cash to buy up shares at these levels. Because although it may be frustrating to see my AMBS in the red, it also gives more people a nice entry point, or allow people to accumulate. Today I made it to "LONG" status. I bought my first 20,000 shares 1 year and 1 day ago. Still own every single share I ever bought. Go AMBS!